A new “lab-on-a-chip” platform developed at the Institute of Photonic Sciences in Spain is capable of detecting detect very low concentrations of protein cancer markers, enabling diagnoses of the disease in its earliest stages. The device, just a few square centimeters in size, uses recent advances in plasmonics, nano-fabrication, microfluids and surface chemistry.
Researchers at Massachusetts Institute of Technology and the Univ. of Vienna have created an imaging system that reveals neural activity throughout the brains of living animals. This technique, the first that can generate 3-D movies of entire brains at the millisecond timescale, could help scientists discover how neuronal networks process sensory information and generate behavior.
Univ. of Utah researchers devised a way to watch newly forming AIDS virus particles emerging or “budding” from infected human cells without interfering with the process. The method shows a protein named ALIX gets involved during the final stages of virus replication, not earlier, as was believed previously.
A new study could help resolve a longstanding debate about the origins of the first people to inhabit the Americas, researchers report in Science. The study relies on genetic information extracted from the tooth of an adolescent girl who fell into a sinkhole in the Yucatan 12,000 to 13,000 years ago.
If studying a single gene or a diet that might extend longevity is like searching for a fountain of youth, then a new study calls for looking at something more like the whole watershed. Brown Univ. biologists who experimentally throttled three such factors in fruit flies found that lifespan depended more on interactions among the factors than on the factors themselves.
A new study reveals that a protein of the Ebola virus can transform into three distinct shapes, each with a separate function that is critical to the virus’s survival. Each shape offers a potential target for developing drugs against Ebola virus disease, a hemorrhagic fever that kills up to nine out of 10 infected patients in outbreaks such as the current one in West Africa.
Researchers at the National Physical Laboratory and the London Centre for Nanotechnology have determined the structure of DNA from measurements on a single molecule using atomic force microscopy (AFM), and found significant variations in the well-known double helix.
In pharmaceutical production, identifying enzyme catalysts that help improve the speed and efficiency of the process can be a major boon. Figuring out exactly why a particular enzyme works so well is an altogether different quest. Take the cholesterol-lowering drug simvastatin.
The human body is full of proteins called enzymes that help nearly every function in the body. Scientists have been studying enzymes for decades in order to learn how they work and how to create better drugs and medical treatments for many ailments. Now, Univ. of Missouri researchers have completed a 3-D map of an enzyme called Proline utilization A (PutA).
The final step in the production of a biotech medicine is finishing with the correct sugar structure. This step is essential for the efficacy of the medicine, but it also makes the production process very complex and expensive. Researchers in Belgium have developed a technology that shortens the sugar structures whilst retaining the therapeutic efficiency. This technology could make production of biotech medicines simpler and cheaper.
A key step in the decades-long mystery of the HIV lifecycle was uncovered using what formerly was thought of as only a supplementary x-ray technique for structural biology. This advances study of HIV as well as highlights a powerful tool to obtain currently unobtainable high-resolution structural determination and characterization of RNA molecules.
In 2003, when the human genome had been sequenced, many people expected a welter of new therapies to follow, as biologists identified the genes associated with particular diseases. But the process that translates genes into proteins turned out to be much more involved than anticipated. Other elements also regulate protein production, complicating the relationship between an organism’s genetic blueprint and its physical characteristics.
A new study shows that lowering temperatures for two hours each day reduces the height of corn without affecting its seed yield. The technique could be used to grow crops in controlled-environment facilities in caves and former mines.
In new work, a research team has shed light on a type of molecular motor used to package the DNA of a number of viruses, including such human pathogens as herpes and the adenoviruses. The scientists found that this viral packaging motor exerts torque to rotate DNA and adapts to changing conditions in order to coordinate its mechano-chemical activity.
Plant scientists at Brookhaven National Laboratory have found that certain enzymes responsible for desaturating fatty acids, the building blocks of oils, can link up to efficiently pass intermediate products from one enzyme to another. The research lead to the development of plants that can accumulate high levels of more healthful polyunsaturated fatty acids, or fatty acids that could be used as raw materials in place of petroleum.
Biomedical engineering researchers have developed an anti-cancer drug delivery method that essentially smuggles the drug into a cancer cell before triggering its release. The method can be likened to keeping a cancer-killing bomb and its detonator separate until they are inside a cancer cell, where they then combine to destroy the cell.
Ice cream lovers and hot tea drinkers with sensitive teeth could one day have a reason to celebrate a new finding from Duke Univ. researchers. The scientists have found a very small change in a single protein that turns a cold-sensitive receptor into one that senses heat.
Scripps Research Institute scientists have engineered a bacterium whose genetic material includes an added pair of DNA “letters,” or bases, not found in nature. The cells of this unique bacterium can replicate the unnatural DNA bases more or less normally, for as long as the molecular building blocks are supplied.
The frequency of a new tick-borne infection that shares many similarities with Lyme disease, and a description of the antibody test used to test individuals for evidence of the infection, have been reported for the first time by researchers at the Yale Schools of Public Health and Medicine.
Tumors shrank or disappeared and disease progression was temporarily halted in 15 children with advanced neuroblastoma enrolled in a safety study of an experimental antibody produced at St. Jude Children's Research Hospital. Four patients are still alive after more than two-and-a-half years and without additional treatment.
No x-ray facility in the world has supported more protein structure research and characterized more proteins than the Advanced Photon Source at Argonne National Laboratory. Soon this 2/3-mile-in-circumference x-ray instrument will get a boost in efficiency that likely will translate into a big boon for the discovery of new pharmaceuticals and the control of genetic disorders and other diseases, as well as advancing the biotech industry.
Researchers in Pennsylvania have created an artificial chemical sensor based on one of the human body’s most important receptors, one that is critical in the action of painkillers and anesthetics. In these devices, the receptors’ activation produces an electrical response rather than a biochemical one, allowing that response to be read out by a computer.
From time to time, genetic codes aren’t copied and collated properly, leaving gaps or breaks. A comprehensive mapping of these “fragile sites” in yeast by a team of Duke Univ. researchers shows that errors appear in specific areas of the genome where the DNA-copying machinery is slowed or stalled. The study could shed light on abnormalities seen in solid tumors.
Rice Univ. scientists have designed a tunable virus that works like a safe deposit box. It takes two keys to open it and release its therapeutic cargo. The Rice team developed an adeno-associated virus (AAV) that unlocks only in the presence of two selected proteases, enzymes that cut up other proteins for disposal. Because certain proteases are elevated at tumor sites, the viruses can be designed to target and destroy the cancer cells.
Johns Hopkins Univ. biochemists have figured out what is needed to activate and sustain the virus-fighting activity of an enzyme found in CD4+ T cells, the human immune cells infected by HIV. The discovery could launch a more effective strategy for preventing the spread of HIV in the body with drugs targeting this enzyme, they say.